Ethical considerations: Both the drugs are safe, effective evidence-based prophylactic uterotonics to prevent PPH. However, the protocol will be approved by all relevant Institutional Review Boards prior to enrollment of study participants. Only authorized study personnel will have access to study supplies and documents.